CM-16

N/A

Report date: 2025/01/26 16:34:58
NME

Base Information

Drug NameCM-16
Drug Alias NameCM-16
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranslation pathway modulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversite Libre De Bruxelles
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A